CMR Surgical is a British medical device company headquartered in Cambridge, UK. It specializes in producing the Versius Surgical Robotic System, a robot-assisted surgery platform aimed at transforming minimal access surgery globally. Since its inception, CMR Surgical has grown rapidly, achieving unicorn status and securing significant funding rounds, including a recent $200 million investment in 2025 to support expansion, particularly in the United States.
The company focuses on making robotic-assisted surgery accessible to a wider patient base by providing a versatile, modular, and flexible system that competes with established platforms like the Da Vinci Surgical System. CMR Surgical collaborates with numerous NHS hospitals in the UK and has a global presence spanning Europe, Latin America, Asia, Middle East, Africa, and Australia.
CMR Surgical actively engages in lobbying activities in the EU with a focus on advancing the regulatory and innovation ecosystem for medical devices and surgical robotics. Their transparency filings outline their lobbying goals related to surgical robotics policy, medical device regulations, and healthcare innovation frameworks. The company holds registrations in the EU Transparency Register and complies with its code of conduct for lobbying transparency.
